Polymorphisms of the angiotensin converting enzyme gene in early-onset and late-onset pre-eclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 8, 2010, Pages 874-879

  Uma, Ramalingam ^a   Forsyth, Stewart J ^a   Struthers, Allan D ^a   Fraser, Callum G ^b   Godfrey, Valerie ^a   Murphy, Deirdre J ^c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

ACE genotype; early onset pre eclampsia; serum angiotensin converting enzyme

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ACID BASE BALANCE; ADULT; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; PREECLAMPSIA; PRIORITY JOURNAL; RECURRENCE RISK; GENETICS; NEWBORN; PREGNANCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INFANT, NEWBORN; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; RENIN-ANGIOTENSIN SYSTEM; YOUNG ADULT;

EID: 77954756737     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767050903456667     Document Type: Article

References (34)

1. Buchbinder A, Sibai BM, Caritis S, Macpherson C, Vandorsten P, Hauth J, Lindheimer MD, Landon M, Klebanoff M, Paul R, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002; 186:66-71.
2. Lain KY, Krohn MA, Roberts JM. Second pregnancy outcomes following preeclampsia in a first pregnancy. Hypertens Pregnancy 2005;24:159-169.
3. Rasmussen S, Irgens LM. History of fetal growth restriction is more strongly associated with severe rather than milder pregnancy-induced hypertension. Hypertension 2008;51: 1231-1238.
4. Mostello D, Catlin TK, Roman L, Holcomb WL, Jr, Leet T. Preeclampsia in the parous woman: who is at risk? Am J Obstet Gynecol 2002;187:425-429.
5. Koike T, Minakami H, Izumi A, Watanabe T, Matsubara S, Sato I. Recurrence risk of preterm birth due to preeclampsia. Gynecol Obstet Invest 2002;53:22-27.
6. Rasmussen S, Irgens LM, Albrechtsen S, Dalaker K. Predicting preeclampsia in the second pregnancy from low birth weight in the first pregnancy. Obstet Gynecol 2000;96: 696-700.
7. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972;1:177-191.
8. Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 2002;187:1416-1423.
9. Shah DM. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol 2005;288:F614-F625.
10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86: 1343-1346.
11. Morgan T, Craven C, Ward K. Human spiral artery reninangiotensin system. Hypertension 1998;32:683-687.
12. Kaur R, Jain V, Khuller M, Gupta I, Sherawat BS. Association of angiotensin-converting enzyme gene polymorphism with pregnancy-induced hypertension. Acta Obstet Gynecol Scand 2005;84:929-933.
13. Kobashi G, Hata A, Shido K, Ohat K, Yamada H, Kato EH, Minakami H, Tamashiro H, Fujimoto S, Kondo K. Insertion/ deletion polymorphism of the angiotensin-converting enzyme gene and preeclampsia in Japanese patients. Semin Thromb Hemost 2005;31:346-350
14. Morgan L, Foster F, Hayman R, Crawshaw S, Baker PN, Pipkin FB, Kalsheker N. Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and preeclamptic pregnancies. J Hypertension 1999;17:765-768.
15. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.
16. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003;22:143-148.
17. Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992;339:283-287.
18. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl 1993;3:120-121.
19. Galao AO, de Souza LH, da Costa BE, Scheibe RM, Poli de Figueiredo CE. Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy. Am J Obstet Gynecol 2004;191:821-824.
20. Mello G, Parretti E, Gensini F, Genuardi M, Abbati R, Sticchi E, Mecacci F, Scarsuli G, Fatini C. Maternal-fetal flow, negative events, and preeclampsia: role of ACE I/D polymorphism. Hypertension 2003;41:932-937.
21. Serrano NC, Diaz LA, Paez MC, Mesa CM, Cifuentes R, Monterrosa A, Gunzalez A, Smeeth L, Hingorini AD, Casas JP. Angiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of small-study bias. PLoS Med 2006;3:e520.
22. Roberts CB, Rom L, Moodley J, Pegoraro RJ. Hypertensionrelated gene polymorphisms in pre-eclampsia, eclampsia and gestational hypertension in black South African women. J Hypertension 2004;22:945-948. (Pubitemid 38680469)
23. Miscovic B, Sertic J, Stavljenic-Rukavina A, Stipoljev F. Association of angiotensin-converting enzyme insertiondeletion polymorphism with preeclampsia. Coll Antropol 2008;32:339-343.
24. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991;165:1408-1412.
25. Hnat MD, Sibai BM, Caritis S, Hauth J, Lindheimer MD, MacPherson C, VanDorsten JP, Landon M, Miodovnik M, Paul R, et al. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol 2002;186:422-426.
26. Ito M, Itakura A, Ohno Y, Nomura M, Senga T, Nagasaka T, Mizutani S. Possible activation of the renin-angiotensin system in the feto-placental unit in preeclampsia. J Clin Endocrinol Metab 2002;87:1871-1878.
27. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682-2689.
28. Campbell JH, Tachas G, Black MJ, Cockerill G, Campbell GR. Molecular biology of vascular hypertrophy. Basic Res Cardiol 1991;86 (Suppl 1):3-11.
29. Herse F, Dechend R, Harsem NK, Wallukat G, Janke J, Quadri F, Hering L, Muller DN, Luft FC, Staff AC. Dysregulation of the circulating and tissue-based reninangiotensin system in preeclampsia. Hypertension 2007;49: 604-611.
30. Penesova A, Cizmarova E, Kvetnansky R, Koska J, Sedlakova B, Krizanova O. Insertion/deletion polymorphism on ACE gene is associated with endothelial dysfunction in young patients with hypertension. Horm Metab Res 2006;38:592-597.
31. Methot J, Hamelin BA, Arsenault M, Bogaty P, Plante S, Poirier P. The ACE-DD genotype is associated with endothelial dysfunction in postmenopausal women. Menopause 2006;13:959-966.
32. Vaughan DE. Angiotensin and vascular fibrinolytic balance. Am J Hypertens 2002;15:3S-8S.
33. Matsubara Y, Hayakawa T, Tsuda T, Takeshita E, Watanabe K, Ikeda Y. Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population. Blood Coagul Fibrinolysis 2000;11:115-120.
34. Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF, Abbate R. Lowmolecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 2005;45: 86-91.